Nicholas Stafford

Nicholas Stafford is a Lecturer in the Division of Diabetes, Endocrinology & Gastroenterology (L5) with expertise in cardiovascular research. His work intersects Molecular Biology, Cardiology, and Stem Cell Research, focusing on pathological cardiac remodelling and regenerative therapies.

• Education: PhD (2014) on PMCA1/4 roles in left ventricular hypertrophy and heart failure (supervised by Dr. Elizabeth Cartwright).

His research explores the molecular mechanisms of cardiac diseases, including MicroRNA therapy for myocardial infarction, YAP activation in stem cell-derived cardiomyocytes, and calcium signaling modulation in cardiac fibroblasts. Key themes include foetal gene reactivation, integrin inhibition, and regenerative medicine.

Recent publications highlight his contributions to pathological cardiac remodelling and preclinical studies, with collaborations across institutions. While no formal awards are listed, his work aligns with UN Sustainable Development Goals (SDGs) for health and well-being.

Stafford actively collaborates on projects like Does PMCA4 Inhibition Protect the Heart? (2018–2020) and Calcium Signalling in Cardiac Fibroblasts (2016–2018). His ORCID (0000-0002-7662-3322) provides further details on his research output.